insights_auto
De ce a crescut 4507 2,50%?
Explorează mai multchevron_right
4507:TYO
Shionogi & Co Ltd
3.056,00 JPY
arrow_upward
+2,50%(+74,50) 1 zi
9 nov., 15:30:00 GMT+9 · JPY
search
Toate simbolurile
| Simbol | Preț | Modificare | Modificare % |
|---|
insights_autoSe generează principalele statistici pentru 4507...
Deschide
3.041 JPY
Mare
3.117 JPY
Mic
3.041 JPY
Capitalizarea bursieră
2,72 tril.
Volum mediu
3,37 mil.
Volum
3,16 mil.
Dividende
2,55 %
Dividende trimestriale
19 JPY
Data ex-dividend
29 sept. 2026
Raportul P/V
10,78
Prețul ridicat pe 52 de săptămâni
3.758 JPY
Prețul redus pe 52 de săptămâni
2.584 JPY
Rezultatul pe acțiune
283 JPY
Acțiuni aflate în circulație
314,50 mil.
Nr. de angajați
6 K
Deschide
3.041 JPY
Mare
3.117 JPY
Mic
3.041 JPY
Capitalizarea bursieră
2,72 tril.
Volum mediu
3,37 mil.
Volum
3,16 mil.
Dividende
2,55 %
Dividende trimestriale
19 JPY
Data ex-dividend
29 sept. 2026
Raportul P/V
10,78
Prețul ridicat pe 52 de săptămâni
3.758 JPY
Prețul redus pe 52 de săptămâni
2.584 JPY
Rezultatul pe acțiune
283 JPY
Acțiuni aflate în circulație
314,50 mil.
Nr. de angajați
6 K
Subiecte de știri
Din surse web și de la parteneri de știri
Vietnam.vn
·
acum 2 zile
Indicele Nasdaq a înregistrat a patra săptămână consecutivă de scădere pe piața bursieră americană.
Mecklenburg Times
·
acum 10 minute
Wall St jumps back as oil slide eases inflation worries; Nvidia slumps
ChartMill
·
acum 58 de minute
Most-Active S&P 500 Stocks in Today's Session
Seeking Alpha
·
acum 37 de minute
What Happened To The November Time Target? (SP500)
Profil
Shionogi & Company, Limited is a Japanese pharmaceutical company best known for developing Crestor. Medical supply and brand name also uses katakana.
Shionogi has business roots that date back to 1878, and was incorporated in 1919. Among the medicines produced are for hyperlipidaemia, antibiotics, and cancer medicines.
In Japan it is particularly known as a producer of antimicrobial and antibiotics. Because of antibiotic resistance and slow growth of the antibiotic market, it has teamed up with US based Schering-Plough to become a sole marketing agent for its products in Japan.
Shionogi had supported the initial formation of Ranbaxy Pharmaceuticals, a generic manufacturer based in India. In 2012 the company became a partial owner of ViiV Healthcare, a pharmaceutical company specialising in the development of therapies for HIV.
The company is listed on the Tokyo Stock Exchange and Osaka Securities Exchange and is constituent of the Nikkei 225 stock index.
In June 2023, Shionogi announced its acquisition of Qpex Biopharma for approximately $140m.
On 5 October 2026, Shionogi announced an agreement to acquire IntraBio for US$2 billion through its US subsidiary, Shionogi Inc. Wikipedia
Despre Shionogi & Co Ltd
Director executivIsao Teshirogi
Angajați6,22 K
Înființată la5 iun. 1919
Sediu-
DomeniuHealth Care
Domeniu de activitate-
Siteshionogi.com